Related Experiment Videos

Management of antihypertensive treatment with Lisinopril: a chronotherapeutic approach

C Macchiarulo1, R Pieri, D C Mitolo

  • 1Dept Clinical Methodology and Medico-Surgical Technologies, Medical School, University of Bari, Italy.

Insights

Optimizing hypertension treatment, taking Lisinopril at 10:00 PM offers better cardiovascular protection. This chronotherapy approach aligns drug delivery with the body's natural blood pressure rhythms, reducing morning cardiovascular risk.

Area of Science:

  • Cardiology
  • Pharmacology
  • Chronobiology

Background:

  • Cardiovascular events peak in the early morning due to circadian blood pressure (BP) variability.
  • Traditional once-daily antihypertensive medication, often taken in the morning, shows diminished efficacy towards the end of the dosing interval.
  • Optimizing drug timing based on circadian BP patterns and chronorisk is crucial for hypertensive patients with vascular conditions.

Purpose of the Study:

  • To evaluate the impact of administering ACE-inhibitor Lisinopril (20 mg/day) at different times (8:00 AM, 4:00 PM, 10:00 PM) on blood pressure control.
  • To determine the optimal dosing time for Lisinopril to enhance therapeutic effects and mitigate morning cardiovascular risk.

Main Methods:

  • 40 patients with mild to moderate primary hypertension underwent 24-hour ambulatory blood pressure monitoring (ABPM).
  • Patients were randomized to receive Lisinopril at 8:00 AM, 4:00 PM, or 10:00 PM, with ABPM repeated every two months while adjusting the dosing time.
  • Chronobiological analysis was performed on ABPM data before and after treatment to assess BP changes and circadian rhythm patterns.

Main Results:

  • Lisinopril administration at all tested times resulted in a significant reduction in systolic and diastolic BP without altering the circadian BP rhythm.
  • A more pronounced reduction in BP was observed between 6:00 AM and 11:00 AM following the 10:00 PM dosing regimen.
  • Nighttime administration (10:00 PM) provided superior protection against morning cardiovascular risk compared to morning or afternoon dosing.

Conclusions:

  • Administering Lisinopril at 10:00 PM is more effective in managing hypertension and reducing cardiovascular risk.
  • This chronotherapeutic approach, by aligning medication with the circadian BP pattern, offers enhanced protection against morning vascular events and the Cruickshank effect.
  • Chronobiologist antihypertensive treatment represents a valuable strategy to augment the efficacy of traditional hypertension management.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...